Codeine / Lean

Codeine is a narcotic opioid derived from morphine, medically used in controlled doses as a cough suppressant and mild pain reliever. "Lean" or "purple drank" refers to the recreational abuse of codeine-based cough syrups, typically mixed with carbonated drinks (Sprite, Fanta) and sometimes sweets, creating a sweet, thick purple-coloured beverage. The name and culture around it was popularised by American hip-hop music and rapidly spread into Nigerian youth culture through social media. At its peak in 2018, a BBC Africa Eye investigation revealed that approximately 3 million bottles of codeine-based cough syrup were being consumed daily in Nigeria — primarily in Kano State, but with significant spread to the Southeast.

The 2018 NAFDAC ban on over-the-counter codeine cough syrups was a direct response to this crisis. The ban removed the most accessible form of codeine from Nigerian pharmacies. However, the ban did not eliminate the problem — it shifted users to more potent and dangerous opioids, primarily tramadol and, in some areas, to illicitly manufactured codeine syrup and imported alternatives. The ban's impact illustrates both a policy success (reduced accessibility) and an unintended consequence (opioid substitution), underscoring the need for concurrent treatment and harm reduction services.

Codeine's lethality is primarily a function of dose and combination. At therapeutic doses (15–30mg), it is a safe medication. At the doses consumed in "lean" (typically 500–1000mg+ in a single session), it causes profound respiratory depression — the breathing rate slows to a dangerous degree. When combined with alcohol, benzodiazepines, or tramadol — which is extremely common in Nigerian abuse patterns — the respiratory depression becomes synergistic and fatal. The user simply stops breathing, often while appearing to be asleep. This is the mechanism behind the majority of opioid overdose deaths.

Codeine creates full opioid dependence. Within weeks of heavy use, the brain's natural endorphin system shuts down, and users cannot manage normal discomfort, anxiety, or stress without the drug. Withdrawal — characterised by intense muscle cramps, diarrhoea, insomnia, sweating, and profound anxiety — typically begins within 8–12 hours of the last dose and peaks at 72 hours. Without medical support, the severity of codeine withdrawal is a primary driver of relapse.